BRIEF-Shield-Utah Study Shows Novavax's Covid-19 Vaccine Induces Lower Reactogenicity Symptoms Compared To Mrna

Reuters
15 Apr
BRIEF-Shield-Utah Study Shows Novavax's Covid-19 Vaccine Induces Lower Reactogenicity Symptoms Compared To Mrna

April 15 (Reuters) - Novavax Inc NVAX.O:

  • SHIELD-UTAH STUDY SHOWS NOVAVAX'S COVID-19 VACCINE INDUCES LOWER REACTOGENICITY SYMPTOMS COMPARED TO MRNA

Source text: ID:nPn6wL8N2a

Further company coverage: NVAX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10